GOOG
81
-2
STI
12
-7
ADT
32
4
EQT
45
-3
WHR
59
-2
NWSA
71
-4
PEP
33
-3
PRU
50
3
MMM
40
3
BIIB
42
2
GM
63
2
ECL
54
-3
EW
57
2
VFC
58
2
PSX
29
2
WYNN
36
2
D
37
2
PRGO
36
3
XYL
33
2
GOOGL
64
-2
GOOG
81
-2
STI
12
-7
ADT
32
4
EQT
45
-3
WHR
59
-2
NWSA
71
-4
PEP
33
-3
PRU
50
3
MMM
40
3
BIIB
42
2
GM
63
2
ECL
54
-3
EW
57
2
VFC
58
2
PSX
29
2
WYNN
36
2
D
37
2
PRGO
36
3
XYL
33
2
GOOGL
64
-2
Financhill
Back

ProQR Therapeutics NV 10K Form

Sell
16

PRQR
ProQR Therapeutics NV

Last Price:
$2.69
Seasonality Move:
2.98%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive PRQR News And Ratings

See the #1 stock for the next 7 days that we like better than PRQR

PRQR Financial Statistics

Sales & Book Value

Annual Sales: $7.1M
Cash Flow: $-7.1M
Price / Cash Flow: 0
Annual Sales: $0.34
Price / Book: 10.17

Profitability

EPS (TTM): -0.31540
Net Income (TTM): $-26M
Gross Margin: $0
Return on Equity: -66.59%
Return on Assets: -19.08%

ProQR Therapeutics NV Earnings Forecast

Key ProQR Therapeutics NV Financial Ratios

  • The Selling, General & Administrative Expenses for PRQR have been equal to 249.25% of Gross Profit Margin.
  • The Research & Development expenses have been 386.06% of Revenue.
  • The Interest Expense is -4.28% of Operating Income.
  • The Net Earning history of PRQR is -431.67% of Total Revenues.
  • Per Share Earnings over the last 11 years have been positive in 5 years.

ProQR Therapeutics NV Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: PRQR
CUSIP: N71542
Website: proqr.com

Debt

Debt-to-Equity Ratio: 0.18
Current Ratio: 2.33
Quick Ratio: 2.29

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

PRQR Technical Analysis vs Fundamental Analysis

Sell
16
ProQR Therapeutics NV (PRQR) is a Sell

Is ProQR Therapeutics NV a Buy or a Sell?